Alivus Life

{
  "main_header": {
    "sid": 1003513,
    "name": "Alivus Life",
    "stock_name": "Alivus Life",
    "full_name": "Alivus Life Sciences Ltd",
    "name_url": "stocks-analysis/alivus-life",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,120.90",
    "chg": -0.3,
    "chgp": "-0.03%",
    "dir": -1,
    "prev_price": "1,121.20",
    "mcapval": "13,821.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543322,
    "symbol": "ALIVUS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE03Q201024",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "67.49 k",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alivus-life-1003513-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Alivus Life Sciences Gains 4.97%: 4 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-gains-497-4-key-factors-driving-the-weeks-momentum-3983063",
        "imagepath": "",
        "date": "2026-05-09 12:00:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Technical momentum shifts signal bullish outlook</p>\n                    <p><strong>5 May:</strong> Mixed technical signals amid Mojo Grade downgrade</p>\n                    <p><strong>7 May:</strong> Mojo Grade upgraded to Buy following strong quarterly results</p>\n                    <p><strong>7 May:</strong> Bullish momentum confirmed with 4.54% daily gain</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,067.85</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,..."
      },
      {
        "title": "When is the next results date for Alivus Life Sciences Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-alivus-life-sciences-ltd-3982491",
        "imagepath": "",
        "date": "2026-05-08 23:17:21",
        "description": "The next results date for Alivus Life Sciences Ltd is scheduled for 14 May 2026...."
      },
      {
        "title": "Alivus Life Sciences Ltd Upgraded to Buy on Strong Technical and Financial Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-upgraded-to-buy-on-strong-technical-and-financial-performance-3979104",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlivusLifeScien_mojoScore_3979104.png",
        "date": "2026-05-07 08:32:53",
        "description": "Alivus Life Sciences Ltd has seen its investment rating upgraded from Hold to Buy, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 6 May 2026, follows a robust quarter and a bullish shift in market sentiment, positioning the small-cap pharmaceutical company favourably against its peers and broader market benchmarks."
      },
      {
        "title": "Alivus Life Sciences Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-sees-bullish-momentum-shift-amid-strong-technical-signals-3978963",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlivusLifeScien_technicaldot_3978963.png",
        "date": "2026-05-07 08:06:23",
        "description": "Alivus Life Sciences Ltd has demonstrated a marked shift in price momentum, supported by a series of bullish technical indicators that have upgraded its outlook from mildly bullish to bullish. The stock’s recent surge, coupled with positive moving averages and momentum oscillators, signals renewed investor confidence in this small-cap pharmaceutical player."
      },
      {
        "title": "Why is Alivus Life Sciences Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-alivus-life-sciences-ltd-fallingrising-3978548",
        "imagepath": "",
        "date": "2026-05-07 02:03:30",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Robust Price Performance Against Benchmarks</strong></p>\n<p>Alivus Life Sciences has demonstrated impressive returns relative to the broader market. Over the past week, the stock surged by 11.74%, significantly outpacing the Sensex’s modest 0.60% gain. This trend extends over the last month, with the stock appreciating 11.77% compared to the Sensex’s 5.20%. Year-to-date, Alivus Life Sciences has delivered a remarkable 22.48% return, contrasting sharply with the Sensex’s decline of 8.52%. Even on a three-year horizon, the stock’s cumulative gain of 117.22% dwarfs the benchmark’s 27.69% rise, underscoring its strong long-term growth trajectory.</p>\n<p><strong>Intraday and Short-Term Trading Dynamics</strong></p>\n<p>On 06-May, the stock opened with a gap up of 2.07%, signalling early bullish se..."
      },
      {
        "title": "Alivus Life Sciences Ltd Technical Momentum Shifts Amid Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-technical-momentum-shifts-amid-mixed-signals-3975000",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlivusLifeScien_technicaldot_3975000.png",
        "date": "2026-05-05 08:07:41",
        "description": "Alivus Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock’s price action and technical indicators reveal a nuanced picture of strength tempered by caution, reflecting mixed signals across weekly and monthly charts."
      },
      {
        "title": "Alivus Life Sciences Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-technical-momentum-shifts-signal-bullish-outlook-3973823",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlivusLifeScien_technicaldot_3973823.png",
        "date": "2026-05-04 08:02:33",
        "description": "Alivus Life Sciences Ltd has exhibited a notable shift in its technical momentum, transitioning from a mildly bullish stance to a more confident bullish trend. This change is underscored by a combination of moving averages, MACD, and Bollinger Bands indicators, signalling renewed investor interest and potential upside in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Alivus Life Sciences Declines 1.22% Amid Mixed Technical Signals and Hold Rating",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-declines-122-amid-mixed-technical-signals-and-hold-rating-3971455",
        "imagepath": "",
        "date": "2026-05-02 12:00:52",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Apr:</strong> Stock opens at Rs.1,045.45, declines 0.47%</p>\n                    <p><strong>28 Apr:</strong> Downgrade to Hold announced, stock falls 3.52%</p>\n                    <p><strong>29 Apr:</strong> Technical momentum shifts to mildly bullish, price dips further</p>\n                    <p><strong>30 Apr:</strong> Price rebounds 3.19% to close at Rs.1,037.50</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,050.35</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,037.50<..."
      },
      {
        "title": "Alivus Life Sciences Downgraded to Hold Amid Mixed Technical and Valuation Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-3967674",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlivusLifeScien_mojoScore_3967674.png",
        "date": "2026-04-29 08:26:07",
        "description": "Alivus Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 28 April 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technical indicators. Despite strong quarterly financials and robust management efficiency, evolving technical signals and valuation concerns have tempered the stock’s outlook."
      }
    ],
    "total": 284,
    "sid": "1003513",
    "stock_news_url": "https://www.marketsmojo.com/news/alivus-life-sciences-1003513"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "08-May-2026",
      "details": "Enclosed please find herewith the details of Earnings Call slated for Friday May 15 2026 from 8:30 a.m. to 9:30 a.m. (IST) for your information and record.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "07-May-2026",
      "details": "Please find attached herewith Annual Secretarial Compliance Report for the Financial Year ended 31st March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "07-May-2026",
      "details": "Intimation of closure of trading window from April 1 2026 to May 16 2026 (both days inclusive) for the purpose of approval of Audited Financial Results for the quarter and year ended March 31 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "14 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alivus Life Sciences Ltd has declared <strong>250%</strong> dividend, ex-date: 01 Sep 25",
          "dt": "2025-09-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Alivus Life Sciences Gains 4.97%: 4 Key Factors Driving the Week’s Momentum

2026-05-09 12:00:04

Key Events This Week

4 May: Technical momentum shifts signal bullish outlook

5 May: Mixed technical signals amid Mojo Grade downgrade

7 May: Mojo Grade upgraded to Buy following strong quarterly results

7 May: Bullish momentum confirmed with 4.54% daily gain

Week Open

Rs.1,067.85

Week Close

Rs.1,...

Read full news article

When is the next results date for Alivus Life Sciences Ltd?

2026-05-08 23:17:21

The next results date for Alivus Life Sciences Ltd is scheduled for 14 May 2026....

Read full news article

Alivus Life Sciences Ltd Upgraded to Buy on Strong Technical and Financial Performance

2026-05-07 08:32:53

Alivus Life Sciences Ltd has seen its investment rating upgraded from Hold to Buy, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 6 May 2026, follows a robust quarter and a bullish shift in market sentiment, positioning the small-cap pharmaceutical company favourably against its peers and broader market benchmarks.

Read full news article

Alivus Life Sciences Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals

2026-05-07 08:06:23

Alivus Life Sciences Ltd has demonstrated a marked shift in price momentum, supported by a series of bullish technical indicators that have upgraded its outlook from mildly bullish to bullish. The stock’s recent surge, coupled with positive moving averages and momentum oscillators, signals renewed investor confidence in this small-cap pharmaceutical player.

Read full news article

Why is Alivus Life Sciences Ltd falling/rising?

2026-05-07 02:03:30

Robust Price Performance Against Benchmarks

Alivus Life Sciences has demonstrated impressive returns relative to the broader market. Over the past week, the stock surged by 11.74%, significantly outpacing the Sensex’s modest 0.60% gain. This trend extends over the last month, with the stock appreciating 11.77% compared to the Sensex’s 5.20%. Year-to-date, Alivus Life Sciences has delivered a remarkable 22.48% return, contrasting sharply with the Sensex’s decline of 8.52%. Even on a three-year horizon, the stock’s cumulative gain of 117.22% dwarfs the benchmark’s 27.69% rise, underscoring its strong long-term growth trajectory.

Intraday and Short-Term Trading Dynamics

On 06-May, the stock opened with a gap up of 2.07%, signalling early bullish se...

Read full news article

Alivus Life Sciences Ltd Technical Momentum Shifts Amid Mixed Signals

2026-05-05 08:07:41

Alivus Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock’s price action and technical indicators reveal a nuanced picture of strength tempered by caution, reflecting mixed signals across weekly and monthly charts.

Read full news article

Alivus Life Sciences Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-05-04 08:02:33

Alivus Life Sciences Ltd has exhibited a notable shift in its technical momentum, transitioning from a mildly bullish stance to a more confident bullish trend. This change is underscored by a combination of moving averages, MACD, and Bollinger Bands indicators, signalling renewed investor interest and potential upside in the Pharmaceuticals & Biotechnology sector.

Read full news article

Alivus Life Sciences Declines 1.22% Amid Mixed Technical Signals and Hold Rating

2026-05-02 12:00:52

Key Events This Week

27 Apr: Stock opens at Rs.1,045.45, declines 0.47%

28 Apr: Downgrade to Hold announced, stock falls 3.52%

29 Apr: Technical momentum shifts to mildly bullish, price dips further

30 Apr: Price rebounds 3.19% to close at Rs.1,037.50

Week Open

Rs.1,050.35

Week Close

Rs.1,037.50<...

Read full news article

Alivus Life Sciences Downgraded to Hold Amid Mixed Technical and Valuation Signals

2026-04-29 08:26:07

Alivus Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 28 April 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technical indicators. Despite strong quarterly financials and robust management efficiency, evolving technical signals and valuation concerns have tempered the stock’s outlook.

Read full news article

View All News